BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30808393)

  • 1. High penetrance of acute intermittent porphyria in a Spanish founder mutation population and CYP2D6 genotype as a susceptibility factor.
    Barreda-Sánchez M; Buendía-Martínez J; Glover-López G; Carazo-Díaz C; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Rodriguez-Peña L; Serrano-Antón AT; Gil-Ferrer R; Martínez-Romero MDC; Carbonell-Meseguer P; Guillén-Navarro E
    Orphanet J Rare Dis; 2019 Feb; 14(1):59. PubMed ID: 30808393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria.
    Morán-Jiménez MJ; Borrero-Corte MJ; Jara-Rubio F; García-Pastor I; Díaz-Díaz S; Castelbón-Fernandez FJ; Enríquez-de-Salamanca R; Méndez M
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic study of acute intermittent porphyria in Russia: HMBS gene mutation spectrum and problem of penetrance.
    Goncharova M; Pshenichnikova O; Luchinina Y; Pustovoit Y; Karpova I; Surin V
    Clin Genet; 2019 Jul; 96(1):91-97. PubMed ID: 31044425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.
    Guillén-Navarro E; Carbonell P; Glover G; Sánchez-Solís M; Fernández-Barreiro A
    Ann Hum Genet; 2004 Sep; 68(Pt 5):509-14. PubMed ID: 15469427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria.
    Lenglet H; Schmitt C; Grange T; Manceau H; Karboul N; Bouchet-Crivat F; Robreau AM; Nicolas G; Lamoril J; Simonin S; Mirmiran A; Karim Z; Casalino E; Deybach JC; Puy H; Peoc'h K; Gouya L
    Hum Mol Genet; 2018 Apr; 27(7):1164-1173. PubMed ID: 29360981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetrance and predictive value of genetic screening in acute porphyria.
    Baumann K; Kauppinen R
    Mol Genet Metab; 2020 May; 130(1):87-99. PubMed ID: 32067921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.
    Paradisi I; Arias S
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S455-63. PubMed ID: 20978940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria.
    Méndez M; Morán-Jiménez MJ; Gomez-Abecia S; García-Bravo M; Garrido-Astray MC; Fontanellas A; Poblete-Gutiérrez P; Frank J; Enriquez de Salamanca R
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):55-63. PubMed ID: 19656452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation.
    To-Figueras J; Badenas C; Carrera C; Muñoz C; Milá M; Lecha M; Herrero C
    J Inherit Metab Dis; 2006 Aug; 29(4):580-5. PubMed ID: 16817012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
    Yasuda M; Gan L; Chen B; Yu C; Zhang J; Gama-Sosa MA; Pollak DD; Berger S; Phillips JD; Edelmann W; Desnick RJ
    Hum Mol Genet; 2019 Jun; 28(11):1755-1767. PubMed ID: 30615115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.
    Yasuda M; Erwin AL; Liu LU; Balwani M; Chen B; Kadirvel S; Gan L; Fiel MI; Gordon RE; Yu C; Clavero S; Arvelakis A; Naik H; Martin LD; Phillips JD; Anderson KE; Sadagoparamanujam VM; Florman SS; Desnick RJ
    Mol Med; 2015 Jun; 21(1):487-95. PubMed ID: 26062020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
    Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
    Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intermittent porphyria in Argentina: an update.
    Cerbino GN; Gerez EN; Varela LS; Melito VA; Parera VE; Batlle A; Rossetti MV
    Biomed Res Int; 2015; 2015():946387. PubMed ID: 26075277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnostics of acute intermittent porphyria.
    Kauppinen R
    Expert Rev Mol Diagn; 2004 Mar; 4(2):243-9. PubMed ID: 14995910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intermittent porphyria in childhood: a population-based study.
    Hultdin J; Schmauch A; Wikberg A; Dahlquist G; Andersson C
    Acta Paediatr; 2003 May; 92(5):562-8. PubMed ID: 12839285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute intermittent porphyria: Long-term follow up of 35 patients].
    Herrero C; Badenas C; Aguilera P; To-Figueras J
    Med Clin (Barc); 2015 Oct; 145(8):332-7. PubMed ID: 25194977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.
    Bustad HJ; Kallio JP; Vorland M; Fiorentino V; Sandberg S; Schmitt C; Aarsand AK; Martinez A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445488
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.